• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠离子依赖的胆汁盐摄取进入肝脏的结构基础。

Structural basis of sodium-dependent bile salt uptake into the liver.

机构信息

Membrane Protein Mechanisms Group, European Institute of Chemistry and Biology, University of Bordeaux, CNRS-UMR5234, Pessac, France.

Membrane Protein Mechanisms Unit, Institut Pasteur, Paris, France.

出版信息

Nature. 2022 Jun;606(7916):1015-1020. doi: 10.1038/s41586-022-04723-z. Epub 2022 May 11.

DOI:10.1038/s41586-022-04723-z
PMID:35545671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9242856/
Abstract

The liver takes up bile salts from blood to generate bile, enabling absorption of lipophilic nutrients and excretion of metabolites and drugs. Human Na-taurocholate co-transporting polypeptide (NTCP) is the main bile salt uptake system in liver. NTCP is also the cellular entry receptor of human hepatitis B and D viruses (HBV/HDV), and has emerged as an important target for antiviral drugs. However, the molecular mechanisms underlying NTCP transport and viral receptor functions remain incompletely understood. Here we present cryo-electron microscopy structures of human NTCP in complexes with nanobodies, revealing key conformations of its transport cycle. NTCP undergoes a conformational transition opening a wide transmembrane pore that serves as the transport pathway for bile salts, and exposes key determinant residues for HBV/HDV binding to the outside of the cell. A nanobody that stabilizes pore closure and inward-facing states impairs recognition of the HBV/HDV receptor-binding domain preS1, demonstrating binding selectivity of the viruses for open-to-outside over inward-facing conformations of the NTCP transport cycle. These results provide molecular insights into NTCP 'gated-pore' transport and HBV/HDV receptor recognition mechanisms, and are expected to help with development of liver disease therapies targeting NTCP.

摘要

肝脏从血液中摄取胆汁盐以生成胆汁,从而促进脂溶性营养素的吸收和代谢物及药物的排泄。人 Na-牛磺胆酸共转运蛋白(NTCP)是肝脏中主要的胆汁盐摄取系统。NTCP 也是乙型肝炎和丁型肝炎病毒(HBV/HDV)的细胞进入受体,已成为抗病毒药物的重要靶标。然而,NTCP 转运和病毒受体功能的分子机制仍不完全清楚。在这里,我们展示了与人 NTCP 复合物的冷冻电镜结构,揭示了其转运循环的关键构象。NTCP 经历构象转变,打开一个宽的跨膜孔,作为胆汁盐的转运途径,并暴露出关键决定因子残基,用于 HBV/HDV 结合到细胞外。一种稳定孔关闭和内向构象的纳米体,可削弱对 HBV/HDV 受体结合域 preS1 的识别,证明了病毒对 NTCP 转运循环的开放到外向构象的结合选择性,而不是内向构象。这些结果提供了对 NTCP“门控孔”转运和 HBV/HDV 受体识别机制的分子见解,有望有助于开发针对 NTCP 的肝脏疾病治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/247272286945/41586_2022_4723_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/538c9bd04154/41586_2022_4723_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/57f38857bc19/41586_2022_4723_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/cbbd18f08ad1/41586_2022_4723_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/e88a76e65d10/41586_2022_4723_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/38b4f20601cd/41586_2022_4723_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/29900e7e869c/41586_2022_4723_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/25ca6c1c7263/41586_2022_4723_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/0cd22c77c4b2/41586_2022_4723_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/f5db5e2f4165/41586_2022_4723_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/e37b58237321/41586_2022_4723_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/2f918d11e988/41586_2022_4723_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/247272286945/41586_2022_4723_Fig12_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/538c9bd04154/41586_2022_4723_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/57f38857bc19/41586_2022_4723_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/cbbd18f08ad1/41586_2022_4723_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/e88a76e65d10/41586_2022_4723_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/38b4f20601cd/41586_2022_4723_Fig5_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/29900e7e869c/41586_2022_4723_Fig6_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/25ca6c1c7263/41586_2022_4723_Fig7_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/0cd22c77c4b2/41586_2022_4723_Fig8_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/f5db5e2f4165/41586_2022_4723_Fig9_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/e37b58237321/41586_2022_4723_Fig10_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/2f918d11e988/41586_2022_4723_Fig11_ESM.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/9242856/247272286945/41586_2022_4723_Fig12_ESM.jpg

相似文献

1
Structural basis of sodium-dependent bile salt uptake into the liver.钠离子依赖的胆汁盐摄取进入肝脏的结构基础。
Nature. 2022 Jun;606(7916):1015-1020. doi: 10.1038/s41586-022-04723-z. Epub 2022 May 11.
2
Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.乙型肝炎和丁型肝炎病毒的病毒进入以及胆汁盐转运共用牛磺胆酸钠共转运多肽上的共同分子决定因素。
J Virol. 2014 Mar;88(6):3273-84. doi: 10.1128/JVI.03478-13. Epub 2014 Jan 3.
3
Structural insights into the HBV receptor and bile acid transporter NTCP.HBV 受体和胆汁酸转运蛋白 NTCP 的结构见解。
Nature. 2022 Jun;606(7916):1027-1031. doi: 10.1038/s41586-022-04857-0. Epub 2022 May 17.
4
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.牛磺胆酸钠共转运多肽是乙型肝炎病毒和丁型肝炎病毒的功能性受体。
Elife. 2012 Nov 13;1:e00049. doi: 10.7554/eLife.00049.
5
Structure of the bile acid transporter and HBV receptor NTCP.胆酸转运蛋白和 HBV 受体 NTCP 的结构。
Nature. 2022 Jun;606(7916):1021-1026. doi: 10.1038/s41586-022-04845-4. Epub 2022 May 17.
6
Long-term -inhibition of the hepatitis B and D virus receptor NTCP by taurolithocholic acid.牛磺胆酸对乙型肝炎和丁型肝炎病毒受体 NTCP 的长期抑制作用。
Am J Physiol Gastrointest Liver Physiol. 2021 Jan 1;320(1):G66-G80. doi: 10.1152/ajpgi.00263.2020. Epub 2020 Nov 11.
7
Selective hepatitis B and D virus entry inhibitors from the group of pentacyclic lupane-type betulin-derived triterpenoids.五环三萜型白桦脂烷类化合物中乙型和丁型肝炎病毒选择性进入抑制剂。
Sci Rep. 2020 Dec 10;10(1):21772. doi: 10.1038/s41598-020-78618-2.
8
Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.肝胆汁酸摄取转运体和 HBV 进入受体 NTCP 的分子调控。
Biochim Biophys Acta Mol Cell Biol Lipids. 2021 Aug;1866(8):158960. doi: 10.1016/j.bbalip.2021.158960. Epub 2021 Apr 29.
9
Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP.利用临床应用药物作为新型胆酸转运蛋白 NTCP 抑制剂,减少乙型肝炎和丁型肝炎病毒进入。
Sci Rep. 2017 Nov 10;7(1):15307. doi: 10.1038/s41598-017-15338-0.
10
Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.乙型肝炎和丁型肝炎病毒利用牛磺胆酸钠共转运多肽进行种属特异性进入肝细胞。
Gastroenterology. 2014 Apr;146(4):1070-83. doi: 10.1053/j.gastro.2013.12.024. Epub 2013 Dec 19.

引用本文的文献

1
Structure and transport mechanism of the human prostaglandin transporter SLCO2A1.人类前列腺素转运体SLCO2A1的结构与转运机制
Nat Commun. 2025 Aug 30;16(1):8124. doi: 10.1038/s41467-025-63615-8.
2
Updates on Recent Advancements in Hepatitis D Virus Treatment.丁型肝炎病毒治疗的最新进展
Viruses. 2025 Aug 10;17(8):1100. doi: 10.3390/v17081100.
3
Structural basis for cholesterol sensing of LYCHOS and its interaction with indoxyl sulfate.LYCHOS对胆固醇的感知及其与硫酸吲哚酚相互作用的结构基础。

本文引用的文献

1
Clinical effects of NTCP-inhibitor myrcludex B.Myrcludex B 对 NTCP 抑制剂的临床效果。
J Viral Hepat. 2021 Jun;28(6):852-858. doi: 10.1111/jvh.13490. Epub 2021 Feb 28.
2
Megabodies expand the nanobody toolkit for protein structure determination by single-particle cryo-EM.巨球蛋白通过单颗粒冷冻电镜扩展了用于蛋白质结构测定的纳米体工具包。
Nat Methods. 2021 Jan;18(1):60-68. doi: 10.1038/s41592-020-01001-6. Epub 2021 Jan 6.
3
Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction.非均匀细化:自适应正则化可改善单颗粒冷冻电镜重构。
Nat Commun. 2025 Mar 21;16(1):2815. doi: 10.1038/s41467-025-58087-9.
4
Identification of NTCP animal orthologs supporting hepatitis B virus binding and infection.支持乙型肝炎病毒结合与感染的NTCP动物直系同源物的鉴定。
J Virol. 2025 Apr 15;99(4):e0183324. doi: 10.1128/jvi.01833-24. Epub 2025 Mar 5.
5
PGLYRP2 drives hepatocyte-intrinsic innate immunity by trapping and clearing hepatitis B virus.PGLYRP2通过捕获和清除乙型肝炎病毒来驱动肝细胞内在的先天免疫。
J Clin Invest. 2025 Feb 13;135(8). doi: 10.1172/JCI188083. eCollection 2025 Apr 15.
6
ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.ATP结合盒转运体与溶质载体转运体:通过结构和建模方法理解其机制及药物调控
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1602. doi: 10.3390/ph17121602.
7
Dysfunction and regulatory interplay of T and B cells in chronic hepatitis B: immunotherapy and emerging antiviral strategies.慢性乙型肝炎中T细胞和B细胞的功能障碍及调节相互作用:免疫疗法与新兴抗病毒策略
Front Cell Infect Microbiol. 2024 Dec 9;14:1488527. doi: 10.3389/fcimb.2024.1488527. eCollection 2024.
8
Hepatitis B and D virus entry.乙型肝炎病毒和丁型肝炎病毒的进入。
Nat Rev Microbiol. 2025 May;23(5):318-331. doi: 10.1038/s41579-024-01121-2. Epub 2024 Nov 21.
9
The Culprit Behind HBV-Infected Hepatocytes: NTCP.HBV 感染肝细胞的罪魁祸首:NTCP。
Drug Des Devel Ther. 2024 Oct 28;18:4839-4858. doi: 10.2147/DDDT.S480151. eCollection 2024.
10
Structural basis for hepatitis B virus restriction by a viral receptor homologue.乙型肝炎病毒受体同源物限制的结构基础。
Nat Commun. 2024 Oct 25;15(1):9241. doi: 10.1038/s41467-024-53533-6.
Nat Methods. 2020 Dec;17(12):1214-1221. doi: 10.1038/s41592-020-00990-8. Epub 2020 Nov 30.
4
Potent human broadly neutralizing antibodies to hepatitis B virus from natural controllers.来自自然感染者的高效乙型肝炎病毒人源广谱中和抗体。
J Exp Med. 2020 Oct 5;217(10). doi: 10.1084/jem.20200840.
5
Inhibition of Hepatic Bile Acid Uptake by Myrcludex B Promotes Glucagon-Like Peptide-1 Release and Reduces Obesity.美格鲁肽抑制肝脏胆汁酸摄取促进胰高血糖素样肽-1释放并减轻肥胖。
Cell Mol Gastroenterol Hepatol. 2020;10(3):451-466. doi: 10.1016/j.jcmgh.2020.04.009. Epub 2020 Apr 21.
6
Clinical and molecular characterization of four patients with NTCP deficiency from two unrelated families harboring the novel SLC10A1 variant c.595A>C (p.Ser199Arg).两名无关联家系中 4 名 NTCP 缺陷患者的临床和分子特征,携带新型 SLC10A1 变异 c.595A>C(p.Ser199Arg)。
Mol Med Rep. 2019 Dec;20(6):4915-4924. doi: 10.3892/mmr.2019.10763. Epub 2019 Oct 23.
7
The PSIPRED Protein Analysis Workbench: 20 years on.PSIPRED 蛋白质分析工作平台:20 年的发展
Nucleic Acids Res. 2019 Jul 2;47(W1):W402-W407. doi: 10.1093/nar/gkz297.
8
Blocking Sodium-Taurocholate Cotransporting Polypeptide Stimulates Biliary Cholesterol and Phospholipid Secretion in Mice.阻断牛磺胆酸钠共转运多肽可刺激小鼠胆汁胆固醇和磷脂分泌。
Hepatology. 2020 Jan;71(1):247-258. doi: 10.1002/hep.30792. Epub 2019 Aug 13.
9
Consensus designs and thermal stability determinants of a human glutamate transporter.人谷氨酸转运蛋白的共识设计和热稳定性决定因素。
Elife. 2018 Oct 18;7:e40110. doi: 10.7554/eLife.40110.
10
CASTp 3.0: computed atlas of surface topography of proteins.CASTp 3.0:蛋白质表面形貌计算图谱。
Nucleic Acids Res. 2018 Jul 2;46(W1):W363-W367. doi: 10.1093/nar/gky473.